November 29, 2024 Kirkland & Ellis Advises on HK$234 Million H-Share Placing for ImmuneOnco Biopharmaceuticals
November 29, 2024 Kirkland & Ellis Advises on HK$234 Million H-Share Placing for ImmuneOnco Biopharmaceuticals
October 10, 2024 Hong Kong – Kirkland Represents Edding Group On Its Proposed Merger And Reverse Takeover With Genor Biopharma.
October 10, 2024 Hong Kong – Kirkland Represents Edding Group On Its Proposed Merger And Reverse Takeover With Genor Biopharma.
September 11, 2024 Hong Kong – Kirkland Advises Platinum Equity On Financing For Acquisition Of Inventia Healthcare.
September 11, 2024 Hong Kong – Kirkland Advises Platinum Equity On Financing For Acquisition Of Inventia Healthcare.
